Silexan for treatment of anxiety and depression in the context of COVID-19

Eur Neuropsychopharmacol. 2023 May:70:47-48. doi: 10.1016/j.euroneuro.2023.02.015. Epub 2023 Feb 23.
No abstract available

Keywords: Anxiety; COVID-19; Depression; Psychosomatic; Silexan; Subsyndromal.

Publication types

  • Letter

MeSH terms

  • Anxiety / drug therapy
  • COVID-19*
  • Depression / drug therapy
  • Humans
  • Oils, Volatile* / pharmacology
  • Oils, Volatile* / therapeutic use
  • Plant Oils / pharmacology
  • Plant Oils / therapeutic use

Substances

  • lavender oil
  • Plant Oils
  • Oils, Volatile